Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 95 results for "ranbaxy lab"

Pharma's struggle to cope standards paves way for MA deals

Pharma's struggle to cope standards paves way for MA deals

I Two years after its most high-profile regulatory setback to date in the United States - Ranbaxy 's USD 500 million US fine for drug safety violations - India's USD 15 billion a year generic drug industry is still rebuilding its image in its ..., 18 hours ago

5 images for ranbaxy lab

India Infoline, 1 week ago
Business Insider India, 1 week ago, 1 week ago, 2 weeks ago
Money Control, 2 months ago
Financial Express

Sun Pharma shows the door to 18 senior Ranbaxy Labs executives

Sun Pharma, India's largest drugmaker, has reportedly asked 18 senior executives who earlier worked with Ranbaxy Labs, to leave the company, The Economic Times today reported, citing people close to the development. The move comes a year after ...
 Domain-B1 week ago Sun Pharma asks 18 top Ranbaxy executives to leave  Financial Express1 week ago Sun Pharma sacks 18 top ex-Ranbaxy executives  Business Today India1 week ago Sun Pharma hands out walking papers to 18 top Ranbaxy executives  Business Insider India1 week ago

18 top Ranbaxy executives asked to leave

MUMBAI: Sun Pharma has asked 18 top executives of Ranbaxy Labs to leave the firm in one of the biggest culls of senior management professionals in recent times. The order comes a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an ...
 Economic Times1 week ago 18 top Ranbaxy executives including Indrajit Banerjee, Yugal Sikri, get marching orders as part of integration plan with Sun Phama  Times of India1 week ago 18 Ranbaxy execs asked to leave | RIL revamps incentive scheme  Economic Times1 week ago 18 top Ranbaxy executives get marching orders  Economic Times1 week ago
Times of India

Sun Pharma tanks 10% on dismal Q4; Ranbaxy merger seen hurting in short term

Shares of Sun Pharmaceutical Industries tanked nearly 10 percent in early Monday trade, weighed down by lower-than-expected fourth quarter earnings announced Friday as investors reduced their exposure fearing more downside amid sluggish broad market ...
 Firstpost.com4 weeks ago Sun Pharma Q4 profit at Rs 888 crore; Ranbaxy merger hurts  Times of India1 month ago Sun Pharma Q4 profit seen up 9.7%, sales may rise 16%: Poll  Moneycontrol.com1 month ago Buy Sun Pharma; target of Rs 1015: Angel Broking  Moneycontrol.com1 week ago

Remain invested in Divis Lab, says Gaurang Shah

G "One can definitely stay invested in Divis Laboratories . The worry is with Cipla and as a disclosure the price targets that we had set aside was already achieved. So if one gets an uptick, use that uptick and advises to look at Sun Pharma which ...
 Moneycontrol.com2 weeks ago
Money Control

Nifty above 8500; Ranbaxy Labs up 4%, auto stocks in focus

The market gained some strength amid consolidation in afternoon trade. The Sensex climbed 88.75 points to 28046.24 and the Nifty reclaimed 8500, up 21.90 points at 8512.90.
 Money Control2 months ago

Ranbaxy Labs., Ltd. v. Burwell

Spring 2015 Case Name: , 14-cv-1923 BAH, 2015 U.S. Dist. LEXIS 29459 (D.D.C. Mar. 11, 2015) (Howell, J.) Drug Products and Patents-in-Suit: Nexium® (esomeprazole) and Valcyte® (valganciclovir); N/A Nature of the Case and Issues ...
 JD Supra1 month ago Antibacterial Drugs: World Industry and Market Prospects 2015-2025  Biotechgate3 weeks ago
Bangladesh Daily Star

Beximco launches copy of blockbuster hepatitis C drug

BEXIMCO Pharma yesterday announced the launch of the generic version of the wonder drug Sofosbuvir for treating hepatitis C under the brand name Sofovir C. Sofosbuvir is a revolutionary drug recently launched by Gilead Sciences Inc, under its ...
 Bangladesh Daily Star3 hours ago

Drugmakers Dr Reddy's, Wockhardt, Ohm hit by US recall

The three drugmakers have initiated Classs II and III recall of several drugs made at various facilities in India from the US market, the drug regulator of that country has notified Representational Image The US Food and Drug ...
 DNA India9 hours ago

Healthkart's Spun Off 1MG Acquires Homeobuy

Delhi based online vendor of health products Healthkart's generic drug business 1Mg, has acquired online homeopathic drug marketplace Homeobuy for an undisclosed amount. With the acquisition, Homeobuy will be rebranded as 1mgAyush (now operated by ...
 Deal Curry4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less